BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 11159736)

  • 21. Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth.
    Williams CS; Goldman AP; Sheng H; Morrow JD; DuBois RN
    Neoplasia; 1999 Jun; 1(2):170-6. PubMed ID: 10933052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression and NSAID-induced apoptosis in malignant melanomas are independent of cyclooxygenase II.
    Vogt T; McClelland M; Jung B; Popova S; Bogenrieder T; Becker B; Rumpler G; Landthaler M; Stolz W
    Melanoma Res; 2001 Dec; 11(6):587-99. PubMed ID: 11725205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sulindac sulfone inhibits K-ras-dependent cyclooxygenase-2 expression in human colon cancer cells.
    Taylor MT; Lawson KR; Ignatenko NA; Marek SE; Stringer DE; Skovan BA; Gerner EW
    Cancer Res; 2000 Dec; 60(23):6607-10. PubMed ID: 11118042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines.
    Han EK; Arber N; Yamamoto H; Lim JT; Delohery T; Pamukcu R; Piazza GA; Xing WQ; Weinstein IB
    Breast Cancer Res Treat; 1998 Apr; 48(3):195-203. PubMed ID: 9598866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells.
    Agarwal B; Swaroop P; Protiva P; Raj SV; Shirin H; Holt PR
    Apoptosis; 2003 Dec; 8(6):649-54. PubMed ID: 14739610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors.
    Zweifel BS; Davis TW; Ornberg RL; Masferrer JL
    Cancer Res; 2002 Nov; 62(22):6706-11. PubMed ID: 12438270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
    Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
    J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
    Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
    Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonsteroidal anti-inflammatory drugs induce colorectal cancer cell apoptosis by suppressing 14-3-3epsilon.
    Liou JY; Ghelani D; Yeh S; Wu KK
    Cancer Res; 2007 Apr; 67(7):3185-91. PubMed ID: 17409426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2-selective antagonists do not inhibit growth of colorectal carcinoma cell lines.
    Murphy VJ; Yang Z; Rorison KA; Baldwin GS
    Cancer Lett; 1998 Jan; 122(1-2):25-30. PubMed ID: 9464487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meloxicam inhibits the growth of colorectal cancer cells.
    Goldman AP; Williams CS; Sheng H; Lamps LW; Williams VP; Pairet M; Morrow JD; DuBois RN
    Carcinogenesis; 1998 Dec; 19(12):2195-9. PubMed ID: 9886578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased NF-kappaB DNA binding but not transcriptional activity during apoptosis induced by the COX-2-selective inhibitor NS-398 in colorectal carcinoma cells.
    Smartt HJ; Elder DJ; Hicks DJ; Williams NA; Paraskeva C
    Br J Cancer; 2003 Oct; 89(7):1358-65. PubMed ID: 14520472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation.
    Brown WA; Skinner SA; Malcontenti-Wilson C; Vogiagis D; O'Brien PE
    Gut; 2001 May; 48(5):660-6. PubMed ID: 11302965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
    Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis.
    Piazza GA; Rahm AL; Krutzsch M; Sperl G; Paranka NS; Gross PH; Brendel K; Burt RW; Alberts DS; Pamukcu R
    Cancer Res; 1995 Jul; 55(14):3110-6. PubMed ID: 7606732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-regulation of prostaglandin E2 by curcumin is correlated with inhibition of cell growth and induction of apoptosis in human colon carcinoma cell lines.
    Lev-Ari S; Maimon Y; Strier L; Kazanov D; Arber N
    J Soc Integr Oncol; 2006; 4(1):21-6. PubMed ID: 16737669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells.
    Kern MA; Schubert D; Sahi D; Schöneweiss MM; Moll I; Haugg AM; Dienes HP; Breuhahn K; Schirmacher P
    Hepatology; 2002 Oct; 36(4 Pt 1):885-94. PubMed ID: 12297835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of tumor cell invasion by cyclooxygenase inhibitors is mediated by thrombospondin-1 via the early growth response gene Egr-1.
    Moon Y; Bottone FG; McEntee MF; Eling TE
    Mol Cancer Ther; 2005 Oct; 4(10):1551-8. PubMed ID: 16227405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.